Halbert Hargrove Global Advisors, LLC Abbott Laboratories Transaction History

Halbert Hargrove Global Advisors, LLC

$1.76 Billion
Q1 2025

A detailed history of Halbert Hargrove Global Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Halbert Hargrove Global Advisors, LLC holds 92 shares of ABT stock, worth $11,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 22 318.18%

Holding current value

$11,854

Previous $2,000 500.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$111.1 - $140.22 $7,777 - $9,815	70 Added 318.18%	92 $12,000
Q4 2024 Feb 05, 2025	BUY	$111.93 - $119.39 $2,462 - $2,626	22 New	22 $2,000
Q4 2023 Jan 23, 2024	BUY	$90.19 - $110.4 $1.55 Million - $1.9 Million	17,185 New	17,185 $1.89 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $27,798 - $32,720	-287 Reduced 10.29%	2,501 $253,000
Q4 2022 Jan 25, 2023	BUY	$95.06 - $111.52 $11,122 - $13,047	117 Added 4.38%	2,788 $0
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $24,093 - $27,895	249 Added 10.28%	2,671 $259,000
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $5,103 - $6,168	50 Added 2.11%	2,422 $264,000
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $106,608 - $130,002	-935 Reduced 28.27%	2,372 $281,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $7,856 - $9,619	68 Added 2.1%	3,307 $465,000
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $2,916 - $3,226	25 Added 0.78%	3,239 $383,000
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $2,221 - $2,615	21 Added 0.66%	3,214 $373,000
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $11,210 - $13,207	103 Added 3.33%	3,193 $383,000
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $525 - $572	-5 Reduced 0.16%	3,090 $338,000
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $12,554 - $15,246	137 Added 4.63%	3,095 $337,000
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $4,900 - $6,272	64 Added 2.21%	2,958 $270,000
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $31,158 - $45,562	496 Added 20.68%	2,894 $228,000
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $15,544 - $17,305	-198 Reduced 7.63%	2,398 $208,000
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $3,355 - $3,638	-41 Reduced 1.55%	2,596 $217,000
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $5,830 - $6,800	-80 Reduced 2.94%	2,637 $222,000
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $179,919 - $217,523	2,717 New	2,717 $217,000
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $181,207 - $205,282	-2,764 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$60.81 - $73.36 $168,078 - $202,767	2,764 New	2,764 $203,000

Others Institutions Holding ABT

# of Institutions

3,440

Shares Held

1.34B

Call Options Held

10.5M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.

Account

Halbert Hargrove Global Advisors, LLC Abbott Laboratories Transaction History